SCC244

· Haihe Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SCC244, covering 2024-10-09 to 2024-11-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of SCC244 in Patients with Advanced MET Alterations Solid Tumors [Phase 1]